Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

A new COVID-19 vaccine has been approved, but it's not available to everyone. Aerial drone footage shows the humpback whale (Megaptera novaeangliae) missing its iconic lobed fluke, which is ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...

"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...